

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.66341072 |
| 2 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 7.89025269 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 7.34258444 |
| 4 | maintenance of gastrointestinal epithelium (GO:0030277) | 7.24502141 |
| 5 | intestinal epithelial cell development (GO:0060576) | 6.59355918 |
| 6 | regulation of guanylate cyclase activity (GO:0031282) | 6.46484975 |
| 7 | intestinal cholesterol absorption (GO:0030299) | 6.21913246 |
| 8 | glucuronate metabolic process (GO:0019585) | 5.95103067 |
| 9 | uronic acid metabolic process (GO:0006063) | 5.95103067 |
| 10 | actin filament depolymerization (GO:0030042) | 5.56179720 |
| 11 | positive regulation of respiratory burst (GO:0060267) | 5.47977136 |
| 12 | epithelial structure maintenance (GO:0010669) | 5.47576164 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 5.44251256 |
| 14 | flavonoid metabolic process (GO:0009812) | 5.37207057 |
| 15 | O-glycan processing (GO:0016266) | 5.34871336 |
| 16 | digestive system process (GO:0022600) | 5.20290486 |
| 17 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.16485601 |
| 18 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.16485601 |
| 19 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.98066959 |
| 20 | hepatocyte apoptotic process (GO:0097284) | 4.93015255 |
| 21 | angiotensin maturation (GO:0002003) | 4.89957649 |
| 22 | regulation of respiratory burst (GO:0060263) | 4.70884990 |
| 23 | sulfation (GO:0051923) | 4.68265311 |
| 24 | renal system process involved in regulation of blood volume (GO:0001977) | 4.67075665 |
| 25 | vitamin A metabolic process (GO:0006776) | 4.66634504 |
| 26 | bile acid and bile salt transport (GO:0015721) | 4.66391526 |
| 27 | endocrine process (GO:0050886) | 4.66282698 |
| 28 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.66282698 |
| 29 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.66282698 |
| 30 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.56175790 |
| 31 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.53933344 |
| 32 | hemidesmosome assembly (GO:0031581) | 4.50184708 |
| 33 | urea cycle (GO:0000050) | 4.46377232 |
| 34 | urea metabolic process (GO:0019627) | 4.43312937 |
| 35 | ethanol oxidation (GO:0006069) | 4.42761022 |
| 36 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.38319249 |
| 37 | drug metabolic process (GO:0017144) | 4.37593553 |
| 38 | sulfate transmembrane transport (GO:1902358) | 4.35771825 |
| 39 | glomerular filtration (GO:0003094) | 4.28568751 |
| 40 | hormone catabolic process (GO:0042447) | 4.28127315 |
| 41 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.18908943 |
| 42 | regulation of systemic arterial blood pressure (GO:0003073) | 4.17942498 |
| 43 | regulation of bile acid biosynthetic process (GO:0070857) | 4.14344592 |
| 44 | lipoprotein transport (GO:0042953) | 4.07575635 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 4.06891827 |
| 46 | antibacterial humoral response (GO:0019731) | 4.03970418 |
| 47 | desmosome organization (GO:0002934) | 4.03689592 |
| 48 | antimicrobial humoral response (GO:0019730) | 4.01603499 |
| 49 | regulation of pseudopodium assembly (GO:0031272) | 4.01387222 |
| 50 | nucleotide-sugar metabolic process (GO:0009225) | 4.00803768 |
| 51 | regulation of chemokine secretion (GO:0090196) | 3.99016420 |
| 52 | regulation of cholesterol homeostasis (GO:2000188) | 3.93772447 |
| 53 | drug catabolic process (GO:0042737) | 3.92752212 |
| 54 | regulation of cGMP biosynthetic process (GO:0030826) | 3.92103480 |
| 55 | renal filtration (GO:0097205) | 3.91693075 |
| 56 | transcytosis (GO:0045056) | 3.90517138 |
| 57 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.90064389 |
| 58 | diacylglycerol metabolic process (GO:0046339) | 3.80150613 |
| 59 | oligosaccharide biosynthetic process (GO:0009312) | 3.78314135 |
| 60 | ethanol metabolic process (GO:0006067) | 3.76842453 |
| 61 | sperm capacitation (GO:0048240) | 3.67593909 |
| 62 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.66992995 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65735895 |
| 64 | galactose catabolic process (GO:0019388) | 3.64150967 |
| 65 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63671786 |
| 66 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.63122832 |
| 67 | bicarbonate transport (GO:0015701) | 3.63091370 |
| 68 | GDP-mannose metabolic process (GO:0019673) | 3.61635882 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61565439 |
| 70 | primary alcohol catabolic process (GO:0034310) | 3.61150671 |
| 71 | sulfur amino acid catabolic process (GO:0000098) | 3.60352741 |
| 72 | fructose metabolic process (GO:0006000) | 3.57656303 |
| 73 | sulfate transport (GO:0008272) | 3.56197035 |
| 74 | arginine metabolic process (GO:0006525) | 3.53856696 |
| 75 | lung secretory cell differentiation (GO:0061140) | 3.53351682 |
| 76 | alkaloid metabolic process (GO:0009820) | 3.52733980 |
| 77 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.51490235 |
| 78 | response to hepatocyte growth factor (GO:0035728) | 3.51490235 |
| 79 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.49371650 |
| 80 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.48382126 |
| 81 | protein autoprocessing (GO:0016540) | 3.45880816 |
| 82 | membrane repolarization during action potential (GO:0086011) | 3.44863555 |
| 83 | bile acid metabolic process (GO:0008206) | 3.44186625 |
| 84 | digestion (GO:0007586) | 3.43850326 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.43382150 |
| 86 | drug transmembrane transport (GO:0006855) | 3.42860285 |
| 87 | sulfur compound transport (GO:0072348) | 3.41382570 |
| 88 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.39284657 |
| 89 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.37728195 |
| 90 | thyroid hormone metabolic process (GO:0042403) | 3.37244886 |
| 91 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.35159837 |
| 92 | diol metabolic process (GO:0034311) | 3.34391037 |
| 93 | complement activation, classical pathway (GO:0006958) | 3.33968584 |
| 94 | drug transport (GO:0015893) | 3.33960780 |
| 95 | protein O-linked glycosylation (GO:0006493) | 3.33781083 |
| 96 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.32537312 |
| 97 | phenylpropanoid metabolic process (GO:0009698) | 3.29535912 |
| 98 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.29455746 |
| 99 | cGMP-mediated signaling (GO:0019934) | 3.25812808 |
| 100 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23343416 |
| 101 | glucocorticoid biosynthetic process (GO:0006704) | 3.22177315 |
| 102 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.20540866 |
| 103 | adhesion of symbiont to host cell (GO:0044650) | 3.20440653 |
| 104 | virion attachment to host cell (GO:0019062) | 3.20440653 |
| 105 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.20250202 |
| 106 | regulation of cGMP metabolic process (GO:0030823) | 3.20002590 |
| 107 | regulation of cellular extravasation (GO:0002691) | 3.17194907 |
| 108 | tight junction assembly (GO:0070830) | 3.16254491 |
| 109 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.13608544 |
| 110 | glucose 6-phosphate metabolic process (GO:0051156) | 3.12193658 |
| 111 | transepithelial transport (GO:0070633) | 3.10696617 |
| 112 | cardiac conduction (GO:0061337) | 3.10317335 |
| 113 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10098154 |
| 114 | glycosphingolipid catabolic process (GO:0046479) | 3.09890180 |
| 115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.09047326 |
| 116 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.08379739 |
| 117 | regulation of actin nucleation (GO:0051125) | 3.07900686 |
| 118 | auditory receptor cell differentiation (GO:0042491) | 3.06133950 |
| 119 | regulation of vitamin metabolic process (GO:0030656) | 3.05221311 |
| 120 | glycolipid catabolic process (GO:0019377) | 3.04574460 |
| 121 | NADH metabolic process (GO:0006734) | 3.04208923 |
| 122 | regulation of viral release from host cell (GO:1902186) | 3.04074343 |
| 123 | phospholipid efflux (GO:0033700) | 3.03005603 |
| 124 | cell communication involved in cardiac conduction (GO:0086065) | 3.01341551 |
| 125 | homocysteine metabolic process (GO:0050667) | 2.99535190 |
| 126 | fucose catabolic process (GO:0019317) | 2.96788543 |
| 127 | L-fucose metabolic process (GO:0042354) | 2.96788543 |
| 128 | L-fucose catabolic process (GO:0042355) | 2.96788543 |
| 129 | cellular glucuronidation (GO:0052695) | 2.95398123 |
| 130 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.94940096 |
| 131 | glandular epithelial cell differentiation (GO:0002067) | 2.94498727 |
| 132 | keratinocyte proliferation (GO:0043616) | 2.93597599 |
| 133 | vitamin transmembrane transport (GO:0035461) | 2.93417714 |
| 134 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.93327557 |
| 135 | peptide catabolic process (GO:0043171) | 2.92299911 |
| 136 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91780867 |
| 137 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.90306212 |
| 138 | peptide hormone processing (GO:0016486) | 2.89189798 |
| 139 | thrombin receptor signaling pathway (GO:0070493) | 2.87145574 |
| 140 | sodium ion homeostasis (GO:0055078) | 2.86752718 |
| 141 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.86277255 |
| 142 | eosinophil chemotaxis (GO:0048245) | 2.84666110 |
| 143 | protein-lipid complex assembly (GO:0065005) | 2.84509159 |
| 144 | modified amino acid transport (GO:0072337) | 2.84157958 |
| 145 | striated muscle atrophy (GO:0014891) | 2.83407261 |
| 146 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.78956526 |
| 147 | regulation of triglyceride catabolic process (GO:0010896) | 2.78720894 |
| 148 | positive regulation of pseudopodium assembly (GO:0031274) | 2.78590701 |
| 149 | cytidine catabolic process (GO:0006216) | 2.78402813 |
| 150 | cytidine deamination (GO:0009972) | 2.78402813 |
| 151 | cytidine metabolic process (GO:0046087) | 2.78402813 |
| 152 | lipoprotein metabolic process (GO:0042157) | 2.77208234 |
| 153 | phospholipid scrambling (GO:0017121) | 2.76601628 |
| 154 | exogenous drug catabolic process (GO:0042738) | 2.75835004 |
| 155 | positive regulation of actin filament depolymerization (GO:0030836) | 2.75378449 |
| 156 | plasma lipoprotein particle assembly (GO:0034377) | 2.75291809 |
| 157 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.73892818 |
| 158 | ATP synthesis coupled proton transport (GO:0015986) | 2.73892818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.40213393 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.89578904 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 4.42842346 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.45458926 |
| 5 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 3.43714972 |
| 6 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.42535733 |
| 7 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.32644387 |
| 8 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.20838347 |
| 9 | * SOX2_20726797_ChIP-Seq_SW620_Human | 3.15088555 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.79372822 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.77910129 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.60175513 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.51868149 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.50751147 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.28613909 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.17683601 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16530583 |
| 18 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.13062275 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.11451487 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.08912217 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02641563 |
| 22 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.00219527 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.99501183 |
| 24 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.95040623 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.92969009 |
| 26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.92541598 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.87373055 |
| 28 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.86999727 |
| 29 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.86834047 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85480627 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.81300683 |
| 32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.80267956 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.78739925 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78571926 |
| 35 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.73096631 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.72808113 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.72415942 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.65177836 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63662964 |
| 40 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62597335 |
| 41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62429306 |
| 42 | ATF3_27146783_Chip-Seq_COLON_Human | 1.61219326 |
| 43 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58649611 |
| 44 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.56693312 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54814820 |
| 46 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.54549991 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.54262017 |
| 48 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.51489377 |
| 49 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.46891180 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.46891180 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46596064 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34753376 |
| 53 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.29573906 |
| 54 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28441402 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24297916 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22063107 |
| 57 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.21280511 |
| 58 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21244831 |
| 59 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18426538 |
| 60 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14705626 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14209887 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13249766 |
| 63 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.12025749 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11775300 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11372466 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09058123 |
| 67 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.08644842 |
| 68 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08482029 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08309606 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06508234 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06076908 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05950078 |
| 73 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.04978245 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04197301 |
| 75 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03967217 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02941478 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02390543 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01600323 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.01432554 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01214063 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01192498 |
| 82 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.00309612 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99626029 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98330379 |
| 85 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95832926 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95285768 |
| 87 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95071391 |
| 88 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94988591 |
| 89 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93257150 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92716284 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92562457 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92379889 |
| 93 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.92242700 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91804877 |
| 95 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91450011 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91086058 |
| 97 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90211018 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88071410 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87091452 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86098797 |
| 101 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.85940031 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85156299 |
| 103 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.84961246 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84678583 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82906203 |
| 106 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.82309017 |
| 107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82296312 |
| 108 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82207714 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82037149 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81908106 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81200144 |
| 112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81131543 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80817791 |
| 114 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.80691770 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80476055 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79672731 |
| 117 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.79086232 |
| 118 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79079314 |
| 119 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.78566228 |
| 120 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.78442089 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76605497 |
| 122 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.75581738 |
| 123 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.74581557 |
| 124 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73723984 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.72733035 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.72569122 |
| 127 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71970499 |
| 128 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.70044437 |
| 129 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.69118996 |
| 130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.68803824 |
| 131 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.68134573 |
| 132 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.67852892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.97649351 |
| 2 | MP0005360_urolithiasis | 5.01129741 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 4.50814881 |
| 4 | MP0001666_abnormal_nutrient_absorption | 4.34864004 |
| 5 | MP0000462_abnormal_digestive_system | 4.09283050 |
| 6 | MP0003866_abnormal_defecation | 3.98991245 |
| 7 | MP0001873_stomach_inflammation | 3.36393751 |
| 8 | MP0010155_abnormal_intestine_physiology | 3.15328109 |
| 9 | MP0001663_abnormal_digestive_system | 3.14360105 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 3.06885091 |
| 11 | MP0000537_abnormal_urethra_morphology | 3.04090638 |
| 12 | MP0005381_digestive/alimentary_phenotyp | 2.91749255 |
| 13 | MP0000490_abnormal_crypts_of | 2.86794816 |
| 14 | MP0008004_abnormal_stomach_pH | 2.64824681 |
| 15 | MP0002822_catalepsy | 2.59071850 |
| 16 | MP0001664_abnormal_digestion | 2.43988580 |
| 17 | MP0000477_abnormal_intestine_morphology | 2.37627399 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.37355508 |
| 19 | MP0009379_abnormal_foot_pigmentation | 2.34688608 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.33624568 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.31365047 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22895402 |
| 23 | MP0006054_spinal_hemorrhage | 2.17378178 |
| 24 | MP0003252_abnormal_bile_duct | 2.04140878 |
| 25 | MP0005365_abnormal_bile_salt | 1.95566482 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.89138696 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 1.78986432 |
| 28 | MP0003878_abnormal_ear_physiology | 1.78986432 |
| 29 | MP0005409_darkened_coat_color | 1.74419301 |
| 30 | MP0003283_abnormal_digestive_organ | 1.72500918 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.69658449 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.67440748 |
| 33 | MP0009840_abnormal_foam_cell | 1.60781853 |
| 34 | MP0010329_abnormal_lipoprotein_level | 1.54762465 |
| 35 | MP0002796_impaired_skin_barrier | 1.54252486 |
| 36 | MP0001849_ear_inflammation | 1.50596056 |
| 37 | MP0005670_abnormal_white_adipose | 1.46051743 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.45484148 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.45209683 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.44217275 |
| 41 | MP0004147_increased_porphyrin_level | 1.42604208 |
| 42 | MP0001765_abnormal_ion_homeostasis | 1.32569296 |
| 43 | MP0001764_abnormal_homeostasis | 1.30077017 |
| 44 | MP0000470_abnormal_stomach_morphology | 1.27916326 |
| 45 | MP0004043_abnormal_pH_regulation | 1.27617973 |
| 46 | MP0003868_abnormal_feces_composition | 1.23009326 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.21741891 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.20881756 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.20366491 |
| 50 | MP0004858_abnormal_nervous_system | 1.18497544 |
| 51 | MP0008872_abnormal_physiological_respon | 1.16372821 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.12790040 |
| 53 | MP0003879_abnormal_hair_cell | 1.11684551 |
| 54 | MP0003315_abnormal_perineum_morphology | 1.09932092 |
| 55 | MP0003724_increased_susceptibility_to | 1.08829728 |
| 56 | MP0002098_abnormal_vibrissa_morphology | 1.07406554 |
| 57 | MP0004947_skin_inflammation | 1.06369393 |
| 58 | MP0009384_cardiac_valve_regurgitation | 1.05779143 |
| 59 | MP0000467_abnormal_esophagus_morphology | 1.05531865 |
| 60 | MP0005501_abnormal_skin_physiology | 1.04469335 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.03832852 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.02819106 |
| 63 | MP0005166_decreased_susceptibility_to | 1.00868227 |
| 64 | MP0001188_hyperpigmentation | 1.00048542 |
| 65 | MP0003303_peritoneal_inflammation | 0.92849493 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 0.92847735 |
| 67 | MP0002166_altered_tumor_susceptibility | 0.92702718 |
| 68 | MP0001216_abnormal_epidermal_layer | 0.91591415 |
| 69 | MP0000230_abnormal_systemic_arterial | 0.88633806 |
| 70 | MP0002060_abnormal_skin_morphology | 0.84994629 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82348546 |
| 72 | MP0000613_abnormal_salivary_gland | 0.81772620 |
| 73 | MP0002971_abnormal_brown_adipose | 0.81343625 |
| 74 | MP0005025_abnormal_response_to | 0.78581766 |
| 75 | MP0004484_altered_response_of | 0.77628895 |
| 76 | MP0000609_abnormal_liver_physiology | 0.76235693 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 0.73402987 |
| 78 | MP0005310_abnormal_salivary_gland | 0.73395642 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.73310680 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 0.73237659 |
| 81 | MP0000516_abnormal_urinary_system | 0.73237659 |
| 82 | MP0005332_abnormal_amino_acid | 0.72326771 |
| 83 | MP0009053_abnormal_anal_canal | 0.71282237 |
| 84 | MP0006082_CNS_inflammation | 0.70568073 |
| 85 | MP0005187_abnormal_penis_morphology | 0.70109641 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.68640253 |
| 87 | MP0002132_abnormal_respiratory_system | 0.68026842 |
| 88 | MP0002009_preneoplasia | 0.67743942 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.67273502 |
| 90 | MP0003941_abnormal_skin_development | 0.66700672 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.66411423 |
| 92 | MP0005448_abnormal_energy_balance | 0.66376218 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.66212548 |
| 94 | MP0003436_decreased_susceptibility_to | 0.66013608 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.65738854 |
| 96 | MP0008469_abnormal_protein_level | 0.65688077 |
| 97 | MP0002006_tumorigenesis | 0.65476325 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.65382391 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.65324403 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.64870949 |
| 101 | MP0001790_abnormal_immune_system | 0.64653425 |
| 102 | MP0005387_immune_system_phenotype | 0.64653425 |
| 103 | MP0002896_abnormal_bone_mineralization | 0.63950428 |
| 104 | MP0003329_amyloid_beta_deposits | 0.63833194 |
| 105 | MP0009115_abnormal_fat_cell | 0.62834563 |
| 106 | MP0002254_reproductive_system_inflammat | 0.62733003 |
| 107 | MP0000566_synostosis | 0.60740835 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.60426148 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.59592496 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.59544622 |
| 111 | MP0010771_integument_phenotype | 0.59276201 |
| 112 | MP0009333_abnormal_splenocyte_physiolog | 0.59163698 |
| 113 | MP0005535_abnormal_body_temperature | 0.58964650 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.58415269 |
| 115 | MP0005451_abnormal_body_composition | 0.58000634 |
| 116 | MP0000249_abnormal_blood_vessel | 0.57857914 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.57616842 |
| 118 | MP0000604_amyloidosis | 0.57508339 |
| 119 | MP0001756_abnormal_urination | 0.56601557 |
| 120 | MP0005165_increased_susceptibility_to | 0.54901622 |
| 121 | MP0001835_abnormal_antigen_presentation | 0.52662780 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.52403674 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.50458505 |
| 124 | MP0000377_abnormal_hair_follicle | 0.50255919 |
| 125 | MP0003119_abnormal_digestive_system | 0.47498678 |
| 126 | MP0009785_altered_susceptibility_to | 0.45745296 |
| 127 | MP0008873_increased_physiological_sensi | 0.43634626 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.43385913 |
| 129 | MP0004957_abnormal_blastocyst_morpholog | 0.43357262 |
| 130 | MP0001191_abnormal_skin_condition | 0.42622350 |
| 131 | MP0000383_abnormal_hair_follicle | 0.41420448 |
| 132 | MP0003718_maternal_effect | 0.41418435 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.41294772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 8.75614439 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 7.07326545 |
| 3 | Ventricular fibrillation (HP:0001663) | 4.77780599 |
| 4 | Abdominal distention (HP:0003270) | 4.44503971 |
| 5 | Malnutrition (HP:0004395) | 4.40983978 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.31371466 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 4.05842658 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 3.89699338 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.86794139 |
| 10 | Flat acetabular roof (HP:0003180) | 3.82426221 |
| 11 | Congenital sensorineural hearing impairment (HP:0008527) | 3.79175866 |
| 12 | Pustule (HP:0200039) | 3.78023230 |
| 13 | Hemorrhage of the eye (HP:0011885) | 3.65438204 |
| 14 | Micronodular cirrhosis (HP:0001413) | 3.59300711 |
| 15 | Abnormality of chloride homeostasis (HP:0011422) | 3.50033137 |
| 16 | Metabolic alkalosis (HP:0200114) | 3.48956755 |
| 17 | Hyperaldosteronism (HP:0000859) | 3.42832861 |
| 18 | Gastrointestinal dysmotility (HP:0002579) | 3.42595800 |
| 19 | Villous atrophy (HP:0011473) | 3.42389705 |
| 20 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.42389705 |
| 21 | Rectal prolapse (HP:0002035) | 3.37856689 |
| 22 | Palpitations (HP:0001962) | 3.36486032 |
| 23 | Milia (HP:0001056) | 3.33322136 |
| 24 | Onycholysis (HP:0001806) | 3.31268287 |
| 25 | Abnormal biliary tract morphology (HP:0012440) | 3.31046674 |
| 26 | Abnormality of the 1st metacarpal (HP:0010009) | 3.29734365 |
| 27 | Syncope (HP:0001279) | 3.27415309 |
| 28 | Fragile nails (HP:0001808) | 3.19569808 |
| 29 | Chronic diarrhea (HP:0002028) | 3.18410957 |
| 30 | Woolly hair (HP:0002224) | 3.17195000 |
| 31 | Biliary tract neoplasm (HP:0100574) | 3.09109409 |
| 32 | Abnormal tarsal ossification (HP:0008369) | 3.07294797 |
| 33 | Pili torti (HP:0003777) | 2.99157595 |
| 34 | Atrophic scars (HP:0001075) | 2.86358780 |
| 35 | Acanthocytosis (HP:0001927) | 2.84752465 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 2.84554974 |
| 37 | Hypokalemia (HP:0002900) | 2.81921160 |
| 38 | Fat malabsorption (HP:0002630) | 2.80751392 |
| 39 | Hypobetalipoproteinemia (HP:0003563) | 2.80455106 |
| 40 | Dehydration (HP:0001944) | 2.79449283 |
| 41 | Xanthomatosis (HP:0000991) | 2.78620639 |
| 42 | Cupped ribs (HP:0000887) | 2.76935629 |
| 43 | Complement deficiency (HP:0004431) | 2.74897742 |
| 44 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.74839126 |
| 45 | Abnormality of complement system (HP:0005339) | 2.74118976 |
| 46 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.73648713 |
| 47 | Abnormality of proline metabolism (HP:0010907) | 2.71321565 |
| 48 | Hydroxyprolinuria (HP:0003080) | 2.71321565 |
| 49 | Confusion (HP:0001289) | 2.71190403 |
| 50 | Hyponatremia (HP:0002902) | 2.69408160 |
| 51 | Abnormality of the gastric mucosa (HP:0004295) | 2.69107735 |
| 52 | Glomerulonephritis (HP:0000099) | 2.68168506 |
| 53 | Plantar hyperkeratosis (HP:0007556) | 2.62651705 |
| 54 | Ventricular arrhythmia (HP:0004308) | 2.57261998 |
| 55 | Abnormality of potassium homeostasis (HP:0011042) | 2.55733344 |
| 56 | Late onset (HP:0003584) | 2.54675490 |
| 57 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.53414654 |
| 58 | Eczematoid dermatitis (HP:0000976) | 2.49694819 |
| 59 | Hyperglycinuria (HP:0003108) | 2.48540441 |
| 60 | Ureteral stenosis (HP:0000071) | 2.46060894 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.42344479 |
| 62 | Abnormality of renin-angiotensin system (HP:0000847) | 2.42337399 |
| 63 | Fragile skin (HP:0001030) | 2.40853509 |
| 64 | Neoplasm of the rectum (HP:0100743) | 2.39367575 |
| 65 | Thin bony cortex (HP:0002753) | 2.38747483 |
| 66 | Ventricular tachycardia (HP:0004756) | 2.35668801 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.35660839 |
| 68 | Abnormality of carpal bone ossification (HP:0006257) | 2.35329110 |
| 69 | Microretrognathia (HP:0000308) | 2.35003456 |
| 70 | Abnormality of vitamin B metabolism (HP:0004340) | 2.34013293 |
| 71 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.33358678 |
| 72 | Abnormal foot bone ossification (HP:0010675) | 2.31887922 |
| 73 | Nephritis (HP:0000123) | 2.31257241 |
| 74 | Nausea (HP:0002018) | 2.30507274 |
| 75 | Glycosuria (HP:0003076) | 2.30338026 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 2.30338026 |
| 77 | Wide cranial sutures (HP:0010537) | 2.29540305 |
| 78 | Neoplasm of the small intestine (HP:0100833) | 2.28604919 |
| 79 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.28137609 |
| 80 | Abnormality of glycine metabolism (HP:0010895) | 2.28137609 |
| 81 | Hypotension (HP:0002615) | 2.26922387 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 2.26048699 |
| 83 | Steatorrhea (HP:0002570) | 2.25763857 |
| 84 | Ureteral obstruction (HP:0006000) | 2.23949166 |
| 85 | Decreased circulating renin level (HP:0003351) | 2.21840345 |
| 86 | Uterine neoplasm (HP:0010784) | 2.21161884 |
| 87 | Cheilitis (HP:0100825) | 2.20286801 |
| 88 | Nephrolithiasis (HP:0000787) | 2.19489959 |
| 89 | Esophageal varix (HP:0002040) | 2.19151956 |
| 90 | Curly hair (HP:0002212) | 2.18845674 |
| 91 | Renal tubular acidosis (HP:0001947) | 2.17208658 |
| 92 | Neonatal short-limb short stature (HP:0008921) | 2.15381844 |
| 93 | Progressive sensorineural hearing impairment (HP:0000408) | 2.14641359 |
| 94 | Short phalanx of the thumb (HP:0009660) | 2.14550302 |
| 95 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.13938530 |
| 96 | Posterior subcapsular cataract (HP:0007787) | 2.13906983 |
| 97 | Cerebral palsy (HP:0100021) | 2.11670783 |
| 98 | Hypophosphatemia (HP:0002148) | 2.10768167 |
| 99 | Increased purine levels (HP:0004368) | 2.09988558 |
| 100 | Hyperuricemia (HP:0002149) | 2.09988558 |
| 101 | Hyperammonemia (HP:0001987) | 2.08578445 |
| 102 | Visceral angiomatosis (HP:0100761) | 2.08440357 |
| 103 | Symptomatic seizures (HP:0011145) | 2.06727424 |
| 104 | Widely patent fontanelles and sutures (HP:0004492) | 2.06567602 |
| 105 | Hyperparathyroidism (HP:0000843) | 2.06105086 |
| 106 | Prolonged QT interval (HP:0001657) | 2.05660107 |
| 107 | Abnormality of vitamin metabolism (HP:0100508) | 2.04926433 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 2.03689296 |
| 109 | Abnormality of nucleobase metabolism (HP:0010932) | 2.03192986 |
| 110 | Pancreatitis (HP:0001733) | 2.02628153 |
| 111 | Goiter (HP:0000853) | 2.02459576 |
| 112 | Autoimmune hemolytic anemia (HP:0001890) | 2.01181064 |
| 113 | Metabolic acidosis (HP:0001942) | 2.00895307 |
| 114 | Flattened epiphyses (HP:0003071) | 2.00323064 |
| 115 | Abnormality of sodium homeostasis (HP:0010931) | 1.98207449 |
| 116 | Protuberant abdomen (HP:0001538) | 1.98145649 |
| 117 | Alkalosis (HP:0001948) | 1.93750543 |
| 118 | Hoarse voice (HP:0001609) | 1.92934580 |
| 119 | Abnormal hair laboratory examination (HP:0003328) | 1.92812007 |
| 120 | Glomerulosclerosis (HP:0000096) | 1.90754709 |
| 121 | Adrenal overactivity (HP:0002717) | 1.90721862 |
| 122 | Hypoplasia of dental enamel (HP:0006297) | 1.90093341 |
| 123 | Hyperkalemia (HP:0002153) | 1.90065590 |
| 124 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.89783808 |
| 125 | Short 1st metacarpal (HP:0010034) | 1.89783808 |
| 126 | Abnormality of purine metabolism (HP:0004352) | 1.89367043 |
| 127 | Hypoglycemic coma (HP:0001325) | 1.88990310 |
| 128 | Hyperphosphatemia (HP:0002905) | 1.88363449 |
| 129 | Petechiae (HP:0000967) | 1.87973587 |
| 130 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.87593378 |
| 131 | Increased muscle lipid content (HP:0009058) | 1.87548730 |
| 132 | Growth hormone excess (HP:0000845) | 1.87240038 |
| 133 | Focal segmental glomerulosclerosis (HP:0000097) | 1.86768051 |
| 134 | Progressive hearing impairment (HP:0001730) | 1.86628248 |
| 135 | Ankyloglossia (HP:0010296) | 1.85161943 |
| 136 | Potter facies (HP:0002009) | 1.84161488 |
| 137 | Facial shape deformation (HP:0011334) | 1.84161488 |
| 138 | Flat capital femoral epiphysis (HP:0003370) | 1.82980516 |
| 139 | Dicarboxylic aciduria (HP:0003215) | 1.80469449 |
| 140 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.80469449 |
| 141 | Hemangiomatosis (HP:0007461) | 1.80310280 |
| 142 | Bone pain (HP:0002653) | 1.80200757 |
| 143 | Enlarged epiphyses (HP:0010580) | 1.79876258 |
| 144 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.78468272 |
| 145 | Vertebral hypoplasia (HP:0008417) | 1.78468272 |
| 146 | Pigmentary retinal degeneration (HP:0001146) | 1.77397561 |
| 147 | Periodontitis (HP:0000704) | 1.76563525 |
| 148 | Hypolipoproteinemia (HP:0010981) | 1.75235578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 6.44462641 |
| 2 | ACVR1B | 5.92736428 |
| 3 | MST1R | 5.33340635 |
| 4 | FRK | 5.22372721 |
| 5 | MST4 | 4.40632037 |
| 6 | MAP2K2 | 3.51938936 |
| 7 | PRKG2 | 3.45141064 |
| 8 | NME1 | 3.05940292 |
| 9 | PIK3CA | 2.52124533 |
| 10 | TESK1 | 2.38671194 |
| 11 | EPHA2 | 2.33182536 |
| 12 | RIPK1 | 2.18550871 |
| 13 | EPHB2 | 2.15809683 |
| 14 | MYLK | 2.13502874 |
| 15 | PTK6 | 1.98495818 |
| 16 | MAP3K2 | 1.96657845 |
| 17 | MET | 1.92234305 |
| 18 | FGFR4 | 1.75712653 |
| 19 | NUAK1 | 1.63565666 |
| 20 | MAP2K6 | 1.61644308 |
| 21 | GRK6 | 1.58770028 |
| 22 | STK24 | 1.36139765 |
| 23 | MAP2K1 | 1.32215126 |
| 24 | PBK | 1.29693753 |
| 25 | MAP3K10 | 1.25822574 |
| 26 | TYK2 | 1.21391177 |
| 27 | KSR2 | 1.21269237 |
| 28 | PRPF4B | 1.19529468 |
| 29 | PAK4 | 1.18059908 |
| 30 | PKN2 | 1.16700514 |
| 31 | EPHA3 | 1.16556803 |
| 32 | PTK2 | 1.06898102 |
| 33 | ERBB2 | 1.06244187 |
| 34 | LIMK1 | 1.01272821 |
| 35 | PRKCI | 1.00677227 |
| 36 | TAOK3 | 1.00523474 |
| 37 | ERN1 | 0.98905641 |
| 38 | MAP4K1 | 0.98611747 |
| 39 | FER | 0.97425537 |
| 40 | TTK | 0.96608244 |
| 41 | TAOK1 | 0.93920812 |
| 42 | STK39 | 0.92340423 |
| 43 | SIK1 | 0.88543626 |
| 44 | CAMK2D | 0.86713915 |
| 45 | MAP3K8 | 0.85529474 |
| 46 | MAP3K12 | 0.83856326 |
| 47 | DDR2 | 0.82989680 |
| 48 | FGFR3 | 0.79698602 |
| 49 | STK10 | 0.76644920 |
| 50 | PRKAA2 | 0.74828330 |
| 51 | MATK | 0.74722044 |
| 52 | AURKB | 0.74242821 |
| 53 | MAP3K11 | 0.73724661 |
| 54 | TNIK | 0.72874378 |
| 55 | RPS6KB2 | 0.72400563 |
| 56 | ERBB4 | 0.70131827 |
| 57 | EEF2K | 0.68829046 |
| 58 | MAP3K1 | 0.66674060 |
| 59 | LATS1 | 0.66596503 |
| 60 | ABL2 | 0.64887021 |
| 61 | DMPK | 0.63119716 |
| 62 | IRAK1 | 0.62872681 |
| 63 | MAPK11 | 0.62398330 |
| 64 | CAMK2G | 0.61389808 |
| 65 | MAP3K3 | 0.59914849 |
| 66 | MAP3K7 | 0.58995357 |
| 67 | CAMK2B | 0.58871725 |
| 68 | EPHA4 | 0.58789264 |
| 69 | LRRK2 | 0.56752352 |
| 70 | NLK | 0.53007575 |
| 71 | GRK1 | 0.52691678 |
| 72 | WNK4 | 0.51728811 |
| 73 | PAK1 | 0.49998880 |
| 74 | EPHB1 | 0.48939848 |
| 75 | TESK2 | 0.48846285 |
| 76 | SMG1 | 0.46299881 |
| 77 | DYRK1B | 0.44696124 |
| 78 | PAK3 | 0.44678402 |
| 79 | BMX | 0.44604076 |
| 80 | SCYL2 | 0.43145213 |
| 81 | PRKAA1 | 0.42862808 |
| 82 | NEK1 | 0.41244876 |
| 83 | PIM2 | 0.41201300 |
| 84 | IRAK4 | 0.39367308 |
| 85 | ZAP70 | 0.39142876 |
| 86 | OXSR1 | 0.38043242 |
| 87 | TRIB3 | 0.37056735 |
| 88 | TBK1 | 0.36598932 |
| 89 | RIPK4 | 0.35847522 |
| 90 | PDK3 | 0.35448547 |
| 91 | PDK4 | 0.35448547 |
| 92 | RET | 0.34982468 |
| 93 | PDGFRA | 0.33198673 |
| 94 | PDPK1 | 0.32982831 |
| 95 | PRKCA | 0.32557670 |
| 96 | ROCK1 | 0.31961910 |
| 97 | PRKCZ | 0.31710669 |
| 98 | ICK | 0.31550021 |
| 99 | IKBKE | 0.31367163 |
| 100 | CDK19 | 0.31317746 |
| 101 | JAK1 | 0.30996962 |
| 102 | FYN | 0.29291747 |
| 103 | SRC | 0.29243342 |
| 104 | JAK2 | 0.29150962 |
| 105 | PIK3CG | 0.28232989 |
| 106 | STK38L | 0.27687912 |
| 107 | MAP3K9 | 0.26903460 |
| 108 | CASK | 0.25786693 |
| 109 | MAP3K14 | 0.25736924 |
| 110 | CSK | 0.25495836 |
| 111 | TTN | 0.24975660 |
| 112 | YES1 | 0.24901143 |
| 113 | PAK2 | 0.24828239 |
| 114 | PDK2 | 0.24250394 |
| 115 | BMPR2 | 0.23608099 |
| 116 | CSF1R | 0.23438409 |
| 117 | CSNK1A1 | 0.23147244 |
| 118 | CDK6 | 0.23008042 |
| 119 | PRKCD | 0.22904919 |
| 120 | ARAF | 0.20706796 |
| 121 | IGF1R | 0.20487184 |
| 122 | MAPKAPK2 | 0.19972143 |
| 123 | LYN | 0.19764470 |
| 124 | STK3 | 0.19425497 |
| 125 | PRKACG | 0.18789414 |
| 126 | RPS6KA2 | 0.18029208 |
| 127 | PRKCQ | 0.17818497 |
| 128 | NME2 | 0.16266273 |
| 129 | MELK | 0.16039810 |
| 130 | AKT2 | 0.15972068 |
| 131 | IRAK3 | 0.15305834 |
| 132 | MAPKAPK3 | 0.15286807 |
| 133 | PDK1 | 0.14530454 |
| 134 | BLK | 0.14399464 |
| 135 | CDC42BPA | 0.14023209 |
| 136 | AKT3 | 0.12902141 |
| 137 | KIT | 0.08010291 |
| 138 | IRAK2 | 0.07453598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.89356983 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.90368674 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.89495781 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.49292044 |
| 5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.86481624 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78333588 |
| 7 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.73443642 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.30257082 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.29566252 |
| 10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.26760133 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.23844293 |
| 12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.14457889 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 2.14041227 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 2.02418168 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.92404124 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.80000484 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72605345 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64204998 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.64156228 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63977270 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.63400179 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.58779903 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58595139 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57121026 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54485880 |
| 26 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.53202883 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52479795 |
| 28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.39301248 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31067956 |
| 30 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.25998296 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24268791 |
| 32 | Tight junction_Homo sapiens_hsa04530 | 1.24010615 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20638761 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18154431 |
| 35 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.17221882 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15955824 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13897696 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13314891 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09815518 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08908133 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05469606 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.04954064 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04830579 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00500870 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99800144 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97737307 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96544678 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.94753900 |
| 49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90796899 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89414618 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87460876 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86892621 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.85841397 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.84355770 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82863803 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82553119 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79310945 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78937776 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77306730 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77253938 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76925192 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71312727 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70630429 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69626394 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69623327 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.66547478 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.66070952 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65429786 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.65368047 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.65279854 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64233920 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.62505936 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62438127 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61901615 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61430876 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59317622 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.58333902 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57080109 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.56782295 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56387352 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54367058 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52868777 |
| 83 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.51872674 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51340413 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49656174 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46066535 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45995722 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44427915 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.43075025 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43060169 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42816567 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41262594 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41094697 |
| 94 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40873270 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40748750 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38733888 |
| 97 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36635507 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35288824 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34952770 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.33662998 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32758800 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.29564841 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27868632 |
| 104 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.25465073 |
| 105 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.25077833 |
| 106 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.23376398 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23081712 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.21703171 |
| 109 | Leishmaniasis_Homo sapiens_hsa05140 | 0.21656005 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.19905505 |
| 111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.19634627 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19074996 |
| 113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.17870286 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.17735763 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.17677900 |
| 116 | Ribosome_Homo sapiens_hsa03010 | 0.17339062 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16368492 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15423048 |
| 119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.14987240 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.14962639 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.12889554 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12351576 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.10304627 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.08591763 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.04145682 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.02862367 |

